丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01513 丽珠医药

已收盘 04-26 16:08:20

26.250

-0.100

-0.38%

最高26.800	最低26.100	成交量52.35万
今开26.500	昨收26.350	日振幅2.66%
总市值243.20亿	流通市值81.33亿	总股本9.26亿
成交额1,380万	换手率0.17%	流通股本3.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":26.25,"timestamp":1714118900012,"preClose":26.35,"halted":0,"volume":523494,"delay":0,"floatShares":309831217,"shares":926464448,"eps":2.265283,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.1,"latestTime":"04-26 16:08:20","open":26.5,"high":26.8,"low":26.1,"amount":13797671,"amplitude":0.026565,"askPrice":26.25,"askSize":200,"bidPrice":26.2,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":2.294521900482245,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"adjPreClose":26.35,"dividendRate":0.055483,"openAndCloseTimeList":[[1714095000000,1714104000000],[1714107600000,1714118400000]],"volumeRatio":0.499796,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":38.98,"timestamp":1714115037000,"preClose":39.5,"halted":0,"volume":8895020,"delay":0,"premium":"-37.49"}},"requestUrl":"/m/hq/s/01513","defaultTab":"news","newsList":[{"id":"2430066225","title":"丽珠医药(01513)：注射用醋酸西曲瑞克获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2430066225","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430066225?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:59","pubTimestamp":1714125548,"startTime":"0","endTime":"0","summary":"丽珠医药(01513)发布公告，近日，丽珠医药集团股份有限公司全资子公司丽珠集团丽...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_17.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_17.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111796.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430441182","title":"丽珠医药04月26日获主力加仓198万元 环比增加1700.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430441182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430441182?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:15","pubTimestamp":1714119326,"startTime":"0","endTime":"0","summary":"04月26日, 丽珠医药股价跌0.38%，报收26.25元，成交金额1379万元，换手率0.17%，振幅2.66%，量比0.50。丽珠医药今日主力资金净流入198万元，连续5日净流入，上一交易日主力净流入11万元，今日环比增加1700.00%。该股近5个交易日上涨3.94%，主力资金累计净流入400万元；近20日主力资金累计净流入748万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261615418b563fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261615418b563fc8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430249062","title":"智通AH统计|4月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2430249062","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430249062?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:15","pubTimestamp":1714119306,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止4月26日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1100.00%、749.25%、609.09%；招商银行、比亚迪股份、紫金矿业分列AH溢价率末三位，溢价率分别为20.76%、23.48%、24.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111449.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430298042","title":"南向资金4月25日净买入丽珠医药7.99万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430298042","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430298042?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:31","pubTimestamp":1714095087,"startTime":"0","endTime":"0","summary":"4月25日, 南向资金增持丽珠医药7.99万股，连续5日增持。截止当日收盘，港股通共持有丽珠医药5240.53万股，占流通股16.91%。港股通增持金额前五个股分别为中国银行、香港交易所、快手-W、腾讯控股、中国石油化工股份。丽珠医药近5个交易日上涨1.74%，港股通累计增持146.31万股；近20个交易日下跌4.18%，港股通累计增持160.21万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609421887b143d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609421887b143d5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430470811","title":"丽珠医药(01513)4月25日斥资43.63万港元回购1.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430470811","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430470811?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:34","pubTimestamp":1714041268,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药(01513)发布公告，于2024年4月25日，该公司斥资43.63万港元回购1.67万股，每股回购价为26-26.15港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110174.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430955441","title":"丽珠医药集团股份有限公司成被执行人，被执行金额850.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430955441","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430955441?lang=zh_cn&edition=full","pubTime":"2024-04-25 12:41","pubTimestamp":1714020094,"startTime":"0","endTime":"0","summary":"中国执行信息公开网显示，丽珠医药集团股份有限公司近日新增一则被执行人信息，执行标的850.0元，执行法院为广东省珠海市香洲区人民法院，案件号为（2024）粤0402执3547号。资料显示，丽珠医药集团股份有限公司成立于1985年01月，法定代表人为朱保国，注册资本94358万元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251241348b516f1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251241348b516f1e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429802344","title":"丽珠医药(01513)4月24日耗资约735.79万港元回购28.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429802344","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429802344?lang=zh_cn&edition=full","pubTime":"2024-04-24 17:48","pubTimestamp":1713952128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药(01513)公布，2024年4月24日耗资约735.79万港元回购28.58万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108629.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429317526","title":"南向资金4月23日净买入丽珠医药45.09万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429317526","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429317526?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:31","pubTimestamp":1713922273,"startTime":"0","endTime":"0","summary":"4月23日, 南向资金增持丽珠医药45.09万股，连续3日增持。截止当日收盘，港股通共持有丽珠医药5229.68万股，占流通股16.86%。港股通增持金额前五个股分别为中国银行、腾讯控股、中国移动、农业银行、建设银行。丽珠医药近5个交易日上涨0.59%，港股通累计增持122.61万股；近20个交易日下跌7.04%，港股通累计增持161.49万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240942538b4cbb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240942538b4cbb32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429117027","title":"《业绩》丽珠医药(01513.HK)首季净利润6.08亿人民币  增长4.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429117027","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429117027?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:45","pubTimestamp":1713890700,"startTime":"0","endTime":"0","summary":"丽珠医药(01513.HK) 公布3月止第一季度报告，按中国会计准则，实现营业收入32.43亿人民币(下同)，按年下降5%。归属股东净利润6.08亿元，增长4.5%，每股收益65分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-23 16:25。)过往派息公布日期派息事项派息内容2024/03/28末期业绩普通股息：人民币 1.352023/10/24第三季业绩无派息2023/08/23中期业绩无派息2023/04/20第一季业绩无派息 AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344422/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429160112","title":"【港股通】丽珠医药(01513)首季净利同比增长4.45%至6.08亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2429160112","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429160112?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:55","pubTimestamp":1713869721,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丽珠医药 公告，于2024年一季度，归属公司股东净利润录得6.08亿元，同比增长4.45%。基本每股收益0.65元，同比增长4.84%。期内，营收录得32.43亿元，同比减少4.99%。中药制剂产品实现收入3.89亿元，同比下降29.61%。诊断试剂及设备产品实现收入2.36亿元，同比增长60.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231855428b4a48ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231855428b4a48ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429216230","title":"丽珠医药(01513.HK)一季度归母净利6.08亿元 同比增长4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429216230","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429216230?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:17","pubTimestamp":1713867461,"startTime":"0","endTime":"0","summary":"格隆汇4月23日丨丽珠医药(01513.HK)公告，2024年第一季度报告，公司一季度实现营业收入32.43亿元，同比减少4.99%；归母净利润6.08亿元，同比上涨4.45%；基本每股收益0.65元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231817468b4a2b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231817468b4a2b9c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429164628","title":"丽珠医药(01513)发布一季度业绩 归母净利润6.08亿元 同比增加4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429164628","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429164628?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:16","pubTimestamp":1713867418,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药(01513)发布2024年第一季度报告，该集团期内取得营业收入32.43亿元(人民币，下同)，同比减少4.99%;归母净利润6.08亿元，同比增加4.45%;每股基本盈利0.65元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107670.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150699","title":"丽珠医药04月23日获主力加仓122万元 环比增加577.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150699","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429150699?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:16","pubTimestamp":1713860193,"startTime":"0","endTime":"0","summary":"04月23日, 丽珠医药股价涨0.39%，报收25.75元，成交金额1697万元，换手率0.21%，振幅1.95%，量比0.86。丽珠医药今日主力资金净流入122万元，上一交易日主力净流入18万元，今日环比增加577.78%。该股近5个交易日上涨0.59%，主力资金累计净流出698万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入751万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231617198b49b1bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231617198b49b1bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427139158","title":"【券商聚焦】招银国际料今年中国医药行业有望回归健康增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2427139158","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2427139158?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:56","pubTimestamp":1713250565,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，年初至今，MSCI中国医疗指数下跌22.7%，跑输MSCI中国指数23.3%。展望2024年，随着行业监管常态化进行，新冠基数影响逐渐消退，中国医药行业有望回归健康增长。另外，行业监管仍呈现持续高压态势，预计院内刚需将在下半年出现需求复苏。该行认为，行业严格监管或将常态化，然而，诊疗秩序逐步正常，院内产品和服务的需求仍将保持健康。考虑到基数原因，该行预期行业或将于今年下半年加速增长。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935150","is_publish_highlight":false,"gpt_icon":0},{"id":"2427258560","title":"丽珠医药04月15日主力资金流入311万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427258560","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427258560?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168996,"startTime":"0","endTime":"0","summary":"04月15日, 丽珠医药股价涨1.19%，报收25.50元，成交金额2377万元，换手率0.30%，振幅3.17%，量比1.64。丽珠医药今日主力资金净流入311万元，连续3日净流入，上一交易日主力净流入163万元，今日环比增加90.80%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为0.71%。该股近5个交易日上涨2.41%，主力资金累计净流入1155万元；近20日主力资金累计净流入1518万元，其中净流入天数为12日。该股主力净额占比0.04%，港股市场排名115/2629。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161659877e8f2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161659877e8f2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426338452","title":"丽珠医药(01513.HK)拟4月23日举行董事会会议审批季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2426338452","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426338452?lang=zh_cn&edition=full","pubTime":"2024-04-11 16:45","pubTimestamp":1712825106,"startTime":"0","endTime":"0","summary":"格隆汇4月11日丨丽珠医药(01513.HK)发布公告，董事会兹通告谨定于2024年4月23日(星期二)举行董事会会议，藉以审议及批准公司及其附属公司截至2024年3月31日止三个月的未经审计季度业绩，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041116451287669ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041116451287669ead&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424109816","title":"丽珠医药(01513.HK)累计回购近248万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424109816","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424109816?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:54","pubTimestamp":1712048040,"startTime":"0","endTime":"0","summary":"丽珠医药(01513.HK) (000513.SZ) 公布，截至3月31日通过集中竞价交易方式回购公司A股股份共计215.26万股，占公司总股本的比例为0.23%，每股作价介乎32.95至35.15元人民币，已使用的资金总额为7,343.65万元人民币。此外，截至3月31日公司回购H股共计247.63万股，占公司总股本的比例为0.27%，每股作价介乎23.05至25.15元，已使用的资金总额为6,036.33万元。(jl/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-02 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190626161352536_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190626161352536_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1339637/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2424954062","title":"丽珠医药(01513)累计斥资7343.65万元回购A股共计215.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424954062","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424954062?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:45","pubTimestamp":1712047518,"startTime":"0","endTime":"0","summary":"截至2024年3月31日，公司回购了公司H股股份共计247.63万股，占公司总股本的比例为0.27%，购买的最高价为港币25.15元/股，最低价为港币23.05元/股，已使用的资金总额为港币6036.33万元。上述回购符合公司回购H股的一般授权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1097779.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424033482","title":"丽珠医药(01513)下跌5.07%，报25.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424033482","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424033482?lang=zh_cn&edition=full","pubTime":"2024-04-02 10:43","pubTimestamp":1712025780,"startTime":"0","endTime":"0","summary":"4月2日，丽珠医药(01513)盘中下跌5.07%，截至10:43，报25.3元/股，成交2331.93万元。丽珠医药集团股份有限公司是一家集医药产品研发、生产、销售为一体的综合医药集团公司，主要聚焦消化道、辅助生殖、精神、肿瘤免疫等领域。2022年度，公司营业收入126.30亿元，净利润19.09亿元，研发投入14.01亿元，拥有完善的产品集群以及覆盖研发全周期的差异化产品管线。截至2023年年报，丽珠医药营业总收入124.3亿元、净利润19.54亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/02104340089423.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.livzon.com.cn","stockEarnings":[{"period":"1week","weight":0.0174},{"period":"1month","weight":-0.0241},{"period":"3month","weight":0.0888},{"period":"6month","weight":0.1432},{"period":"1year","weight":0.0136},{"period":"ytd","weight":0.0911}],"compareEarnings":[{"period":"1week","weight":0.0548},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0835},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1252},{"period":"ytd","weight":0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产和销售业务的中国公司。该公司主要产品包括消化道类、心脑血管类、抗微生物药物、促性激素类等西药制剂产品以及中药制剂、原料药和中间体、诊断试剂及设备。该公司的产品销往中国境内和海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.002624},{"month":2,"riseRate":0.636364,"avgChangeRate":0.034763},{"month":3,"riseRate":0.545455,"avgChangeRate":0.026916},{"month":4,"riseRate":0.636364,"avgChangeRate":0.036067},{"month":5,"riseRate":0.4,"avgChangeRate":0.005429},{"month":6,"riseRate":0.5,"avgChangeRate":-0.002448},{"month":7,"riseRate":0.4,"avgChangeRate":-0.047848},{"month":8,"riseRate":0.5,"avgChangeRate":0.002817},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.004127},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.000657},{"month":11,"riseRate":0.6,"avgChangeRate":0.041096},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006188}],"exchange":"SEHK","name":"丽珠医药","nameEN":"LIVZON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠医药,01513,丽珠医药股票,丽珠医药股票老虎,丽珠医药股票老虎国际,丽珠医药行情,丽珠医药股票行情,丽珠医药股价,丽珠医药股市,丽珠医药股票价格,丽珠医药股票交易,丽珠医药股票购买,丽珠医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}